A new approach to identifying genotoxic carcinogens: P53 induction as an indicator of genotoxic damage

Carcinogenesis

Volumn 19, Issue 6, 1998, Pages 1117-1125

  Yang, Jun ^a   Duerksen Hughes, Penelope ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID ETHYL ESTER; AFLATOXIN B1; AZATHIOPRINE; BENZETHONIUM CHLORIDE; CARCINOGEN; DIETHYLSTILBESTROL; DIMETHYL SULFOXIDE; ETHYLNITROSOUREA; METHYLNITRONITROSOGUANIDINE; N (2 FLUORENYL)ACETAMIDE; PHENOL; PROTEIN P53; SACCHARIN;

ANIMAL CELL; ARTICLE; CARCINOGEN TESTING; CONTROLLED STUDY; GENOTOXICITY; HALF LIFE TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE;

ACRYLATES; ANIMALS; CARCINOGENS; CELL LINE; DIETHYLSTILBESTROL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; MICE; MUTAGENS; PHENOL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031926177     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.6.1117     Document Type: Article

References (81)

1. Smart,R.C. (1994) Carcinogenesis. Appleton & Lange, Norwalk, CT.
2. Chu,F.S. (1991) Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures. Mutat. Res., 259, 291-306.
3. Williams,G.M. and Weisburger,J.H. (1991) Chemical Cartinogenesis. Pergamon Press, New York, NY.
4. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res, 113, 173-215.
5. Tennant,R.W. et al. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
6. Zeiger,E., Haseman,J.K., Shelby,M.D., Margolin,B.H. and Tennant R.W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of early results with 41 additional chemicals. Environ. Mol. Muatagen., 16, 1-14.
7. Tennant,R.W., Spalding,J.W., Stasiewicz,S., Caspary,W.D., Mason,J.M. and Resnick,M.A. (1987) Comparative evaluation of genetic toxicity patterns of carcinogens and noncarcinogens: strategies for predictive use of short-term assays. Environ. Hlth Perspect., 75, 87-96.
8. Tennant,R.W. (1991) The genetic toxicology database of the National Toxicology Program: evaluation of the relationships between genetic toxicology and carcinogenicity. Environ. Hlth Perspect., 96, 47-51.
9. Wachsman,J.T., Bristol,D.W., Spalding,J., Shelby,M. and Tennant,R.W. (1993) Predicting chemical carcinogenesis in rodents. Environ. Hlth Perspect., 101, 444-145.
10. Ashby,J. (1997) Comparison of 17 methods of predicting the carcinogenicity of 30 chemicals. Environ. Hlth Perspect., 105, 466-467.
11. Ashby,J. (1996) Prediction of rodent carcinogenicity for 30 chemicals. Environ. Hlth Perspect., 104, 1101-1104.
12. Ashby,J. and Morrod,R.S. (1991) Detection of human carcinogens. Nature, 352, 185-186.
13. Ashby,J. (1996) Alternatives to the 2-species bioassay for the identification of potential human carcinogens. Hum. Exp. Toxicol., 15, 183-202.
14. Todd,M.D., Lee,M.J., Williams,J.L., Nalezny,J.M., Gee, P., Benjamin ,M.B. and Farr,S.B. (1995) The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam. Appl. Toxicol., 28, 118-128.
15. Donehower,L.A. and Bradley,A. (1993) The tumor suppressor p53. Biochim. Biophys. Acta, 1155, 181-205.
16. Haffner,R. and Oren,M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
17. Lee,J.M. and Bernstein,A. (1995) Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev., 14, 149-161.
18. Levine,A.J. (1993) The tumor suppressor genes. Annu. Rev. Biochem., 62, 623-651.
19. Selter,H. and Montenarh,M. (1994) The emerging picture of p53. Int. J. Biochem., 26, 145-154.
20. Greenblat,M.S., Bennet,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
21. Hollstein,M., Sidransky,D., Vogelstein,G. and Harris,C.C. (1991) p53 mutations in human cancer. Science, 253, 49-53.
22. Vogelstein,B. and Kinzler,K.W. (1992) p53 function and dysfunction. Cell, 70, 523-526.
23. Fisher,D.E. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542.
24. DeVita,V.T. and Deisseroth,A.B. (1996) Oncology: resistance to chemotherapy. J. Am. Med. Ass., 275, 1833-1834.
25. Kovach,J.S., Hartmann,A., Blaszyk,H., Cunningham,J., Schaid,D. and Sommer,S.S. (1996) Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc. Natl Acad. Sci. USA, 93, 1093-1096.
26. Brennan,J.A., Mao,L. Hruban,R.H., Bohle,J.O., Eby,Y.J., Koch,W.M., Goodman,S.N. and Sidransky,D. (1995) Molecular assessment of hislopathological staging in squamous-cell carcinoma of the head and neck. New Engl. J. Med., 332, 429-153.
27. El-Deiry,W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
28. Okamoto,K. and Beach,D. (1994) Cyclin G is a trunscriptional target of the p53 tumor suppressor protein. EMBO J., 13, 4816-4822.
29. Shivakumar,C.V., Brown,D.R., Deb,S. and Deb,S.P. (1995) Wild-type human p53 transactivates the human proliferating cell nuclear antigen promotor. Mol. Cell. Biol., 15, 6785-6793.
30. Momand,J., Zambetti,G.P., Olson,D.C., George,D. and Levine,A.J. (1992) The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell, 69, 1237-1245.
31. Barak,Y., Juven,T., Haffner,R. and Oren,M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J., 12, 461-468.
32. Weintraub,H., Hauschka,S. and Tapscott,S.J. (1991) The MCK enhancer contains a p53 responsive element. Proc. Natl Acad. Sci. USA, 88. 4570-4571.
33. Kastan,M.B., Zhan,Q., El-Deiry,W.S., Carrier,F., Jacks,T., Walsh,W.V., Plunkett,B.S., Vogelstein,B. and Fornace,A.J. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71, 587-597.
34. Smith,M.L., Chen,I.-T., Zhan,Q., Bae,I., Chen,C.-Y., Gilmer,T.M., Kastan,M.B., O'Connor,P.M. and Fornace,A.J. Jr (1994) Interaction of the p53-regulated protein GADD45 with proliferation cell nuclear antigen. Science, 266, 1367-1380.
35. Miyashita,T. and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
36. Miyashita,T., Krajewski,S., Krejewska,M., Wang,H.G., Lin,H.K., Liebermann,D.A., Huffman,B. and Reed,J.C. (1994) Tumor suppressor p53 is a regulator of bax-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
37. Han,J., Sabbatini,P., Perez,D., Rao,L., Modha,D. and White,E. (1996) The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev., 10, 461-477.
38. Truant,R., Xiao,H., Ingles,C.J. and Greenblatt,J. (1993) Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem., 268, 2284-2287.
39. Seto,E., Usheva,A., Zambetti,G.P., Momand,J., Horikoshi,N., Weinmann,R., Levine,A.J. and Shenk,T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 89, 12028-12032.
40. Agoff,S.N., Hou,J., Linzer,D.I.H. and Wu,B. (1993) Regulation of the human hsp70 promotor by p53. Science, 259, 84-87.
41. Borellini,F. and Glazer,R.I. (1993) Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem., 268, 7923-7928.
42. Fritsche,M., Haessler,C. and Brandner,G. (1993) Induction of nuclear accumulation of the tumor-suppressing protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
43. Kastan,M.B., Onyekwere,O., Sidransky,D., Vogelstein,N. and Craig,R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
44. Kuerbitz,S.J., Plunkett,B.S., Walsh,W.V. and Kastan,M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
45. Nelson,W.G. and Kastan,M.B. (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14, 1815-1823.
46. Zhan,Q., Carrier,F. and Fornace,A.J.,Jr (1993) Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13, 4242-4250.
47. Hickman,A.W., Jaramillo,R.J., Lechner,J.F. and Johnson,N.F. (1994) α-Particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res., 54, 5797-5800.
48. Hess,R., Plaumann,B., Lutum,A.S., Haessler,C., Heinz,B., Fritsche,M. and Brandner,G. (1994) Nuclear accumulation of p53 in response to treatment with DNA-damaging agents. Toxicol. Lett., 72, 43-52.
49. El-Deiry,W.S. et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
50. Canman,C.E., Gilmer,T.M., Coutts,S.B. and Kastan,M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
51. Lane,D.P. and Crawford,L.V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
52. Narayan,S., Beard,W.A. and Wilson,S.H. (1995) DNA damage-induced transcriptional activation of a human DNA polymerase β chimeric promoter: recruitment of preinitiation complex in vitro by ATF/CREB. Biochemistry, 34, 73-80.
53. Benford,D.J., Price,S.C, Lawrence,J.N., Grasso,P. and Bremmer,J.N. (1994) Investigations of the genotoxicity and cell proliferative activity of dichlorvos in mouse forestomach. Toxicology, 92, 203-215.
54. Bean,C.L., Bradt,C.I., Hill,R., Johnson,T.E., Stallworth,M. and Galloway,S.M. (1994) Chromosome aberrations: persistence of alkylation damage and modulation by O6-alkylguanine-DNA alkyltransferase. Mutat. Res., 307, 67-81.
55. Aidoo,A., Lyn-Cook,L.E., Lensing,S. and Wamer,W. (1994) Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo. Environ. Mol. Mutagen., 24, 220-228.
56. Massey,T.E., Stewart,R.K., Daniels,J.M. and Liu,L. (1995) Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc. Soc. Exp. Biol. Med., 208, 213-227.
57. Stoloff,L. (1977) Aflatoxins - An Overview. Pathtox Publishers, Park Forest South, IL.
58. National Toxicology Program (1991) Sixth Annual Report on Carcinogens: 1991 Summary. US Department of Health and Human Services, Washington, DC.
59. Penn,I. (1988) Tumors of the immunocompromised patient. Annu. Rev. Med., 39, 63-73.
60. Silman,A.J., Petrie,J., Hazleman,B. and Evans,S.J.W. (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Annls Rheum. Dis., 47, 988-992.
61. Confavreux,C., Saddier,P., Grimaud,J., Moreau,T., Adeleine,P. and Aimard,G. (1996) Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology, 46, 1607-1612.
62. Gaylor,D.W., Kadlubar,F.F. and West,R.W. (1988) Estimates of the risk of bladder tumor promotion by saccharin in rats. Regulat. Toxicol. Pharmacol., 8, 467-470.
63. National Toxicology Program (1995) Toxicology and Carcinogenesis Studies of Benzethonium Chloride (CAS 121-54-0) in F344/N Ruts and B6C3F1 Mice (Dermal Studies), NTP technical report 438. US Department of Health and Human Services, Washington, DC.
64. Kolachana,P., Subrahmanyam,V.V., Meyer,K.B., Zhang,L. and Smith,M.T. (1993) Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in viva. Cancer Res., 53, 1023-1026.
65. Yager, J. W., Eastmond,D.A., Robertson,M.L., Paradisin,W.M. and Smith,M.T. (1990) Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res., 50, 393-399.
66. Barale,R., Marrazzini,A., Betti,C., Vangelisti,V., Loprieno,N. and Barrai,I. (1990) Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat. Res., 244, 15-20.
67. Hellmer,L. and Bolcsfoldi,G. (1992) An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. I. In vitro sensitivity of the bacteria to 61 compounds. Mutat. Res., 272, 145-160.
68. Batiste-Alentorn,M., Xamena,N., Creus,A. and Marcos,R. (1994) Further studies with the somatic white-ivory system of Drosophilu melanogaster. genotoxicity testing of ten carcinogens. Environ. Mol. Mutagen., 24, 143-147.
69. Adams,S.P., Laws,G.M., Storer,R.D., DeLuca,J.G. and Nichols,W.W. (1996) Detection of DNA damage induced by human carcinogens in acellular assays: potential application for determining genotoxic mechanisms. Mutat. Res., 368, 235-248.
70. Liehr,J.G. (1990) Genotoxic effects of estrogens. Mutat. Res., 238, 269-276.
71. Gladek,A. and Liehr,J.G. (1989) Mechanism of genotoxicity of diethylstilbestrol in vivo. J. Biol. Chem., 264, 16847-16852.
72. Moore,M.M., Parker,L., Huston,J., Harrington-Brock,K. and Dearfield,K.L. (1991) Comparison of mutagenicity results for nine compounds evaluated at the hgprt locus in the standard and suspension CHO assays. Mutagenesis. 6, 77-85.
73. Przybojewska,B., Dziubaltowska,E. and Kowalski,Z. (1984) Genotoxic effects of ethyl acrylate and methyl acrylate in the mouse evaluated by the micronucleus test. Mutat. Res., 135, 189-191.
74. Moore,M.M., Amtower,A., Doerr,C.L., Brock,K.H. and Dearfield,K.L. (1988) Genotoxicity of acrylic acid, methyl acrylate, ethyl acrylate, methyl methacrylate, and ethyl methacrylate in L5178Y mouse lymphoma cells. Environ. Mol. Mutagen., 11, 49-63.
75. Wiegand,H.J., Schiffmann,D. and Henschler,D. (1989) Non-genotoxicity of acrylic acid and n-butyl acrylate in a mammalian cell system (SHE cells). Arch. Toxicol., 63, 250-251.
76. Wu,H. and Lozano,G. (1994) NF-κB activation of p53. J. Biol. Chem., 269, 20067-20074.
77. Kessis,T.D., Slebos,R.J., Nelson,W.G., Kastan,M.B., Plunkett,B.S., Han,S.M., Lorincz,A.T., Hedrick,L. and Cho,K.R. (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl Acad. Sci. USA, 90, 3988-3992.
78. Reich,N.C. and Levine,A.J. (1984) Growth regulation of a cellular tumor antigen, p53. in nontransformed cells. Nature, 308, 199-201.
79. Gronostajski,R.M., Goldberg,A.L. and Pardee,A.B. (1984) Energy requirement for degradation of tumor-association protein p53. Mol. Cell. Biol., 4, 442-148.
80. Band,V., Dalal,S., Delmolino,L. and Androphy,E.J. (1993) Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mmamary epithelial cells. EMBO J., 12, 1847-1852.
81. Tennant,R.W., French,J.E. and Spalding,J.W. (1995) Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Hlth Perspect., 103, 942-950.